Global Cell and Gene Therapy Drug Delivery Devices Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Description

The Cell and Gene Therapy Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cell and Gene Therapy Drug Delivery Devices size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cell and Gene Therapy Drug Delivery Devices market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Cell and Gene Therapy Drug Delivery Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Sterile Insulin Syringe
    Pre-Filled Syringe
    Infusion Bags

Market segment by Application, can be divided into
    Luxturna
    Kymriah
    Provenge
    Zolgensma
    Yescarta
    Strimvelis

Market segment by players, this report covers
    Amgen, Inc.
    Bausch and Lomb Incorporated
    Becton, Dickinson and Company
    Bluebird bio, Inc.
    Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
    Dendreon Pharmaceuticals LLC.
    Helixmith Co., Ltd (ViroMed Co., Ltd)
    Human Stem Cell Institute
    Kite Pharma, Inc.
    Kolon Tissue Gene, inc.
    Novartis AG
    Orchard Therapeutics plc.
    Pfizer, Inc.
    Renova Therapeutics
    Spark Therapeutics, Inc.
    uniQure N.V.
    Vericel Corporation

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cell and Gene Therapy Drug Delivery Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cell and Gene Therapy Drug Delivery Devices, with revenue, gross margin and global market share of Cell and Gene Therapy Drug Delivery Devices from 2019 to 2021.
Chapter 3, the Cell and Gene Therapy Drug Delivery Devices competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Cell and Gene Therapy Drug Delivery Devices market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Cell and Gene Therapy Drug Delivery Devices research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cell and Gene Therapy Drug Delivery Devices
    1.2 Classification of Cell and Gene Therapy Drug Delivery Devices by Type
        1.2.1 Overview: Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type in 2020
        1.2.3 Sterile Insulin Syringe
        1.2.4 Pre-Filled Syringe
        1.2.5 Infusion Bags
    1.3 Global Cell and Gene Therapy Drug Delivery Devices Market by Application
        1.3.1 Overview: Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Luxturna
        1.3.3 Kymriah
        1.3.4 Provenge
        1.3.5 Zolgensma
        1.3.6 Yescarta
        1.3.7 Strimvelis
    1.4 Global Cell and Gene Therapy Drug Delivery Devices Market Size & Forecast
    1.5 Global Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast by Region
        1.5.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region, (2016-2021)
        1.5.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)
        1.5.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)
        1.5.6 South America Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Cell and Gene Therapy Drug Delivery Devices Market Drivers
        1.6.2 Cell and Gene Therapy Drug Delivery Devices Market Restraints
        1.6.3 Cell and Gene Therapy Drug Delivery Devices Trends Analysis

2 Company Profiles
    2.1 Amgen, Inc.
        2.1.1 Amgen, Inc. Details
        2.1.2 Amgen, Inc. Major Business
        2.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.1.4 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Amgen, Inc. Recent Developments and Future Plans
    2.2 Bausch and Lomb Incorporated
        2.2.1 Bausch and Lomb Incorporated Details
        2.2.2 Bausch and Lomb Incorporated Major Business
        2.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.2.4 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Bausch and Lomb Incorporated Recent Developments and Future Plans
    2.3 Becton, Dickinson and Company
        2.3.1 Becton, Dickinson and Company Details
        2.3.2 Becton, Dickinson and Company Major Business
        2.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Becton, Dickinson and Company Recent Developments and Future Plans
    2.4 Bluebird bio, Inc.
        2.4.1 Bluebird bio, Inc. Details
        2.4.2 Bluebird bio, Inc. Major Business
        2.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.4.4 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Bluebird bio, Inc. Recent Developments and Future Plans
    2.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
        2.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Details
        2.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business
        2.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments and Future Plans
    2.6 Dendreon Pharmaceuticals LLC.
        2.6.1 Dendreon Pharmaceuticals LLC. Details
        2.6.2 Dendreon Pharmaceuticals LLC. Major Business
        2.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans
    2.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
        2.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Details
        2.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business
        2.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments and Future Plans
    2.8 Human Stem Cell Institute
        2.8.1 Human Stem Cell Institute Details
        2.8.2 Human Stem Cell Institute Major Business
        2.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.8.4 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Human Stem Cell Institute Recent Developments and Future Plans
    2.9 Kite Pharma, Inc.
        2.9.1 Kite Pharma, Inc. Details
        2.9.2 Kite Pharma, Inc. Major Business
        2.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.9.4 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Kite Pharma, Inc. Recent Developments and Future Plans
    2.10 Kolon Tissue Gene, inc.
        2.10.1 Kolon Tissue Gene, inc. Details
        2.10.2 Kolon Tissue Gene, inc. Major Business
        2.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.10.4 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Kolon Tissue Gene, inc. Recent Developments and Future Plans
    2.11 Novartis AG
        2.11.1 Novartis AG Details
        2.11.2 Novartis AG Major Business
        2.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.11.4 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Novartis AG Recent Developments and Future Plans
    2.12 Orchard Therapeutics plc.
        2.12.1 Orchard Therapeutics plc. Details
        2.12.2 Orchard Therapeutics plc. Major Business
        2.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.12.4 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Orchard Therapeutics plc. Recent Developments and Future Plans
    2.13 Pfizer, Inc.
        2.13.1 Pfizer, Inc. Details
        2.13.2 Pfizer, Inc. Major Business
        2.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.13.4 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Pfizer, Inc. Recent Developments and Future Plans
    2.14 Renova Therapeutics
        2.14.1 Renova Therapeutics Details
        2.14.2 Renova Therapeutics Major Business
        2.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.14.4 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Renova Therapeutics Recent Developments and Future Plans
    2.15 Spark Therapeutics, Inc.
        2.15.1 Spark Therapeutics, Inc. Details
        2.15.2 Spark Therapeutics, Inc. Major Business
        2.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Spark Therapeutics, Inc. Recent Developments and Future Plans
    2.16 uniQure N.V.
        2.16.1 uniQure N.V. Details
        2.16.2 uniQure N.V. Major Business
        2.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.16.4 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 uniQure N.V. Recent Developments and Future Plans
    2.17 Vericel Corporation
        2.17.1 Vericel Corporation Details
        2.17.2 Vericel Corporation Major Business
        2.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Solutions
        2.17.4 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 Vericel Corporation Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Cell and Gene Therapy Drug Delivery Devices Players Market Share
        3.2.2 Top 10 Cell and Gene Therapy Drug Delivery Devices Players Market Share
        3.2.3 Market Competition Trend
    3.3 Cell and Gene Therapy Drug Delivery Devices Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue and Market Share by Type (2016-2021)
    4.2 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application (2016-2021)
    5.2 Cell and Gene Therapy Drug Delivery Devices Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)
    6.2 North America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)
    6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
        6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2026)
        6.3.2 United States Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        6.3.3 Canada Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        6.3.4 Mexico Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)
    7.2 Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)
    7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country
        7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2026)
        7.3.2 Germany Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        7.3.3 France Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        7.3.5 Russia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        7.3.6 Italy Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)
    8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)
    8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region
        8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2016-2026)
        8.3.2 China Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        8.3.3 Japan Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        8.3.4 South Korea Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        8.3.5 India Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        8.3.7 Australia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)
    9.2 South America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)
    9.3 South America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
        9.3.1 South America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2026)
        9.3.2 Brazil Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        9.3.3 Argentina Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)
    10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)
    10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country
        10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2026)
        10.3.2 Turkey Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)
        10.3.4 UAE Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Cell and Gene Therapy Drug Delivery Devices Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2021-2026)
    Table 6. Amgen, Inc. Corporate Information, Head Office, and Major Competitors
    Table 7. Amgen, Inc. Major Business
    Table 8. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 9. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Bausch and Lomb Incorporated Corporate Information, Head Office, and Major Competitors
    Table 11. Bausch and Lomb Incorporated Major Business
    Table 12. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 13. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Becton, Dickinson and Company Corporate Information, Head Office, and Major Competitors
    Table 15. Becton, Dickinson and Company Major Business
    Table 16. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 17. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Bluebird bio, Inc. Corporate Information, Head Office, and Major Competitors
    Table 19. Bluebird bio, Inc. Major Business
    Table 20. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 21. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Corporate Information, Head Office, and Major Competitors
    Table 23. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business
    Table 24. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 25. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Dendreon Pharmaceuticals LLC. Corporate Information, Head Office, and Major Competitors
    Table 27. Dendreon Pharmaceuticals LLC. Major Business
    Table 28. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 29. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Helixmith Co., Ltd (ViroMed Co., Ltd) Corporate Information, Head Office, and Major Competitors
    Table 31. Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business
    Table 32. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 33. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Human Stem Cell Institute Corporate Information, Head Office, and Major Competitors
    Table 35. Human Stem Cell Institute Major Business
    Table 36. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 37. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Kite Pharma, Inc. Corporate Information, Head Office, and Major Competitors
    Table 39. Kite Pharma, Inc. Major Business
    Table 40. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 41. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Kolon Tissue Gene, inc. Corporate Information, Head Office, and Major Competitors
    Table 43. Kolon Tissue Gene, inc. Major Business
    Table 44. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 45. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Novartis AG Corporate Information, Head Office, and Major Competitors
    Table 47. Novartis AG Major Business
    Table 48. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 49. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Orchard Therapeutics plc. Corporate Information, Head Office, and Major Competitors
    Table 51. Orchard Therapeutics plc. Major Business
    Table 52. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 53. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Pfizer, Inc. Corporate Information, Head Office, and Major Competitors
    Table 55. Pfizer, Inc. Major Business
    Table 56. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 57. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Renova Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 59. Renova Therapeutics Major Business
    Table 60. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 61. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Spark Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
    Table 63. Spark Therapeutics, Inc. Major Business
    Table 64. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 65. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 66. uniQure N.V. Corporate Information, Head Office, and Major Competitors
    Table 67. uniQure N.V. Major Business
    Table 68. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 69. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 70. Vericel Corporation Corporate Information, Head Office, and Major Competitors
    Table 71. Vericel Corporation Major Business
    Table 72. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Solutions
    Table 73. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 74. Global Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) by Players (2019-2021)
    Table 75. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players (2019-2021)
    Table 76. Breakdown of Cell and Gene Therapy Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 77. Cell and Gene Therapy Drug Delivery Devices Players Head Office, Products and Services Provided
    Table 78. Cell and Gene Therapy Drug Delivery Devices Mergers & Acquisitions in the Past Five Years
    Table 79. Cell and Gene Therapy Drug Delivery Devices New Entrants and Expansion Plans
    Table 80. Global Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) by Type (2016-2021)
    Table 81. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Type (2016-2021)
    Table 82. Global Cell and Gene Therapy Drug Delivery Devices Revenue Forecast by Type (2021-2026)
    Table 83. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021)
    Table 84. Global Cell and Gene Therapy Drug Delivery Devices Revenue Forecast by Application (2021-2026)
    Table 85. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)
    Table 86. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)
    Table 87. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)
    Table 88. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)
    Table 89. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2021) & (USD Million)
    Table 90. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
    Table 91. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)
    Table 92. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)
    Table 93. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)
    Table 94. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)
    Table 95. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2021) & (USD Million)
    Table 96. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
    Table 97. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)
    Table 98. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)
    Table 99. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)
    Table 100. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)
    Table 101. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2016-2021) & (USD Million)
    Table 102. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2021-2026) & (USD Million)
    Table 103. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)
    Table 104. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)
    Table 105. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)
    Table 106. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)
    Table 107. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2021) & (USD Million)
    Table 108. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
    Table 109. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)
    Table 110. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)
    Table 111. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)
    Table 112. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)
    Table 113. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2021) & (USD Million)
    Table 114. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Cell and Gene Therapy Drug Delivery Devices Picture
    Figure 2. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type in 2020
    Figure 3. Sterile Insulin Syringe
    Figure 4. Pre-Filled Syringe
    Figure 5. Infusion Bags
    Figure 6. Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application in 2020
    Figure 7. Luxturna Picture
    Figure 8. Kymriah Picture
    Figure 9. Provenge Picture
    Figure 10. Zolgensma Picture
    Figure 11. Yescarta Picture
    Figure 12. Strimvelis Picture
    Figure 13. Global Cell and Gene Therapy Drug Delivery Devices Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 14. Global Cell and Gene Therapy Drug Delivery Devices Revenue and Forecast (2016-2026) & (USD Million)
    Figure 15. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2016-2026)
    Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region in 2020
    Figure 17. North America Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Europe Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. South America Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. Cell and Gene Therapy Drug Delivery Devices Market Drivers
    Figure 23. Cell and Gene Therapy Drug Delivery Devices Market Restraints
    Figure 24. Cell and Gene Therapy Drug Delivery Devices Market Trends
    Figure 25. Amgen, Inc. Recent Developments and Future Plans
    Figure 26. Bausch and Lomb Incorporated Recent Developments and Future Plans
    Figure 27. Becton, Dickinson and Company Recent Developments and Future Plans
    Figure 28. Bluebird bio, Inc. Recent Developments and Future Plans
    Figure 29. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments and Future Plans
    Figure 30. Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans
    Figure 31. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments and Future Plans
    Figure 32. Human Stem Cell Institute Recent Developments and Future Plans
    Figure 33. Kite Pharma, Inc. Recent Developments and Future Plans
    Figure 34. Kolon Tissue Gene, inc. Recent Developments and Future Plans
    Figure 35. Novartis AG Recent Developments and Future Plans
    Figure 36. Orchard Therapeutics plc. Recent Developments and Future Plans
    Figure 37. Pfizer, Inc. Recent Developments and Future Plans
    Figure 38. Renova Therapeutics Recent Developments and Future Plans
    Figure 39. Spark Therapeutics, Inc. Recent Developments and Future Plans
    Figure 40. uniQure N.V. Recent Developments and Future Plans
    Figure 41. Vericel Corporation Recent Developments and Future Plans
    Figure 42. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players in 2020
    Figure 43. Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 44. Global Top 3 Players Cell and Gene Therapy Drug Delivery Devices Revenue Market Share in 2020
    Figure 45. Global Top 10 Players Cell and Gene Therapy Drug Delivery Devices Revenue Market Share in 2020
    Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 47. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Type in 2020
    Figure 48. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Type (2021-2026)
    Figure 49. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Application in 2020
    Figure 50. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Application (2021-2026)
    Figure 51. North America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)
    Figure 52. North America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)
    Figure 53. North America Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Country (2016-2026)
    Figure 54. United States Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Canada Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Mexico Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Europe Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)
    Figure 58. Europe Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)
    Figure 59. Europe Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Country (2016-2026)
    Figure 60. Germany Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. France Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. United Kingdom Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Russia Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Italy Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)
    Figure 66. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)
    Figure 67. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2016-2026)
    Figure 68. China Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Japan Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. South Korea Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. India Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Australia Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. South America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)
    Figure 75. South America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)
    Figure 76. South America Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Country (2016-2026)
    Figure 77. Brazil Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Argentina Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)
    Figure 80. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)
    Figure 81. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Country (2016-2026)
    Figure 82. Turkey Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 83. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 84. UAE Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation